IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
about
1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activityChimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumorsIs the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.Role of regulatory dendritic cells in allergy and asthma.Mouse and human dendritic cell subtypes.The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infectionProteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.Regulatory T cells and autoimmune disease.Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.Immunoregulation of dendritic cellsInhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.A defect in tryptophan catabolism impairs tolerance in nonobese diabetic miceCTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.Dendritic cells and tumor microenvironment: a dangerous liaisonModulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenaseHarnessing the immune system to treat cancer.Indoleamine 2,3-dioxygenase and tumor-induced toleranceDendritic cells: key to fetal tolerance?Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilegeIDO-expressing regulatory dendritic cells in cancer and chronic infection.T-cell death and cancer immune tolerance.Mechanism of T cell tolerance induction by murine hepatic Kupffer cells.Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisGM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditisIndoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.Cytokine treatment of macrophage suppression of T cell activation.Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells.Novel findings in drug-induced dendritic cell tolerogenicity.Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Advances in the cellular immunological pathogenesis of type 1 diabetesAryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research
P2860
Q27863347-8CFB3DC5-BD9C-44ED-82B9-8DA69C217BB8Q28484683-F8041B94-0013-4C3F-A6DC-05038D2634E7Q28610462-5B0AC30A-57E1-4A32-9A14-2A334B6C41B4Q33968156-686031F6-4467-43A2-B1A3-3B7651BF07EDQ34554298-58FF761B-6E6C-4FB7-84CE-71B5398B1B28Q34576401-C07A094E-7C4D-4EF5-83D9-B6E2A4C59B98Q34657284-BBB93237-CA93-4A52-B9CB-50BCF123CE1EQ34657500-F624720C-7663-492B-9A74-8995F61AC65EQ34657796-B59C8483-985D-4CCD-BB3B-8C47EFF5856EQ35131219-0C6534E2-FA7B-4784-8854-95A78EC83663Q35366959-40706A6D-D0B3-48CB-93C2-7E2A78CDE0D5Q35603220-A51262C1-20CC-4D28-B1DA-144B184CDCE4Q36079905-501D0433-0EB6-4D1B-A2AC-B9424E2B5FB0Q36154801-9C4A4993-83E4-4484-9515-A74CA6AB1A12Q36256306-335456E0-3289-4C38-8936-880659A4386AQ36376598-A4937F89-4FAC-4361-84CA-170C6D1E800CQ36376640-BD5CCF76-7DA5-4910-813A-4655B9E8F029Q36399304-F71CB9CF-4A2C-4072-A117-8CF676D16A78Q36569018-7CAC32E1-C4A9-4B75-8785-7D1148EF098AQ36632492-C689A90F-5422-45CB-B31B-9DD1CCE639EDQ36809755-08EB2332-4DAD-46D9-8835-D2839DBB50FCQ36809762-E3C960AB-ADCE-4E6A-8E77-6A7263488A6BQ36862971-21668589-8490-47DA-9B89-D5FDBEA857B8Q36899012-D1420221-1FC9-4700-8007-25589C7A4D0CQ36944802-07313842-EBDD-40D0-9F6E-54B5D29C095EQ37002795-4B3F2EE0-A841-41F0-B8DB-DA184D5847B8Q37010267-92E6230F-BAB5-4A60-8B9A-2A24FD962B62Q37039994-9EF3F0D3-3F89-48AF-B0AD-F5BB179828F8Q37081582-A2961F0D-D29E-4E51-A92B-921DB641E263Q37104636-5F828D08-B463-4457-90B7-1E0D9A431F9FQ37301247-3DFAA04C-91F9-4266-BD5C-1CA33BAC4253Q37334065-6469396A-2B12-4B98-87B9-E5A9D0A06648Q37352554-CAD35C1A-A600-48BD-AF1E-0CE249498882Q37399728-8EDBF033-66C0-40D0-8F51-0B1B6F6C3024Q37417083-CFC48EA1-ED5C-4E96-AC2F-EE081FD4F299Q37809070-57501EF3-45D5-4281-8B54-D8D07B2B8A06Q38032201-00B0BB73-173C-4225-A33E-15633372568CQ38110540-82949F36-6B1C-47A3-81AE-BD3CB1B61A0DQ38195946-2525343C-B300-4F2C-8469-31A2CB8919B9Q38268639-F180644F-3D26-4723-A699-8C6F79E74F4E
P2860
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@en
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@nl
type
label
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@en
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@nl
prefLabel
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@en
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@nl
P2093
P1476
IL-6 inhibits the tolerogenic ...... g indoleamine 2,3-dioxygenase.
@en
P2093
Belladonna ML
Fallarino F
Fioretti MC
Grohmann U
Puccetti P
Uyttenhove C
P304
P356
10.4049/JIMMUNOL.167.2.708
P407
P577
2001-07-01T00:00:00Z